Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HCW Biologics (HCWB) EPS (Basic) (2020 - 2025)

HCW Biologics (HCWB) has disclosed EPS (Basic) for 6 consecutive years, with -$2.02 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EPS (Basic) rose 51.09% year-over-year to -$2.02, compared with a TTM value of $10.86 through Sep 2025, up 152.24%, and an annual FY2024 reading of -$0.77, down 10.0% over the prior year.
  • EPS (Basic) was -$2.02 for Q3 2025 at HCW Biologics, up from -$6.79 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $19.72 in Q4 2024 and bottomed at -$16.16 in Q2 2024.
  • Average EPS (Basic) over 5 years is -$0.6, with a median of -$0.14 recorded in 2023.
  • Peak annual rise in EPS (Basic) hit 6673.33% in 2024, while the deepest fall reached 13366.67% in 2024.
  • Year by year, EPS (Basic) stood at $0.05 in 2021, then tumbled by 420.0% to -$0.16 in 2022, then tumbled by 87.5% to -$0.3 in 2023, then soared by 6673.33% to $19.72 in 2024, then crashed by 110.24% to -$2.02 in 2025.
  • Business Quant data shows EPS (Basic) for HCWB at -$2.02 in Q3 2025, -$6.79 in Q2 2025, and -$0.05 in Q1 2025.